About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Autism Spectrum Disorder (ASD)
SCT for Autism: Roger Fazenda's Progress
Patient Profile
Treatment: Stem Cell Therapy (SCT) combined with additional cellular treatment described in the report, rehabilitation therapy, and Traditional Chinese Medicine (TCM)
Initial Condition
At 28 years old, Roger exhibited the following symptoms:
Treatment Course
Upon admission to Puhua International Hospital in January 2012, Roger received:
Progress
After completing the stem cell treatment, Roger demonstrated significant improvements in various aspects of his life:
Family feedback
The family described changes in engagement, eye contact and mood. This personal account does not establish that stem cell treatment caused those changes or that it is effective for autism.
Roger's Journey
The account describes changes reported during a programme that included rehabilitation and other interventions. It cannot establish a benefit attributable to stem cells or predict outcomes for other autistic people.
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Autism Spectrum Disorder (ASD)
Historical Account of Stem Cell Administration and Supportive Care for Autism
Patient Information
Diagnosis: Autism Spectrum Disorder (ASD)
Treatment: Stem Cell Therapy (SCT) combined with Traditional Chinese Medicine (TCM) and physical therapy
History
Kiet was admitted to Beijing Puhua International Hospital due to speech disorders, emotional interaction difficulties, and concentration problems lasting for four years prior to admission.
Medical Condition Before SCT for Autism
SCT for Autism: 21-day protocol
After admission, Kiet received a 21-day SCT protocol for autism, which included:
Medical Condition After SCT for Autism
Post-treatment improvements:
Kiet's physical therapists reported:
Parents' Satisfaction
Kiet's parents expressed great satisfaction with his progress after SCT for autism, noting significant improvements in communication, concentration, and overall behavior.
Special Moment
On the last day of treatment, Kiet held Dr. Gao's hand tightly, looking wistful as if saying, "Don't go, stay with me, I will miss you." This emotional display touched Kiet's parents deeply, as they had never seen him express such sentiment to anyone outside their family.
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Autism Spectrum Disorder (ASD)
Historical Patient Account: Autism
Patient Information
Diagnosis: Autism Spectrum Disorder (ASD)
Medical History:
Akash, a 6-year-old boy from India, was admitted to Beijing Puhua International Hospital with symptoms of speech developmental disorder and limited communication with others for over three years. Prior to treatment:
Biotherapy Treatment for Autism:
Akash received a 21-day biotherapy treatment protocol combining Traditional Chinese Medicine (TCM) and rehabilitation training, focusing on:
Treatment Results:
Before and after images of Akash during rehabilitation training:


Conclusion:
This report describes observed changes during combined care. It does not establish that biotherapy caused those changes or is an effective treatment for autism. We continue to monitor his progress and wish him a bright future filled with further improvements and accomplishments.
About this historical patient account: The information below describes reported observations from one case. It does not establish treatment efficacy, safety, a causal relationship or an expected outcome. Outcomes vary, and reported improvement does not demonstrate cure. Do not change prescribed medicines or delay established care based on this account.
Intervention context: This account does not establish that the cell, growth-factor or other biological interventions described are approved or effective for this diagnosis. Some may be investigational. A qualified specialist should explain the current evidence, regulatory status, alternatives, uncertainties and risks before any treatment decision.
Case Study: Autism Spectrum Disorder (ASD)
Advanced Treatment Protocol for Autism
Patient Information
Diagnosis: Autism Spectrum Disorder (ASD)
Medical History:
Alexei was born healthy, but at around one year old, he started suffering from frequent bronchitis and angina episodes after being infected by his elder brother. At the age of one, he was diagnosed with hypermetropia and organic brain damage. Further examinations revealed hydrocephalus, leading to Alexei being issued a disability certificate.
Alexei displayed various autistic behaviors such as lack of emotion, pain insensitivity, fearlessness, capriciousness, repetitive running, shouting, speech delay, and difficulty sleeping and eating. Despite numerous rehabilitation efforts (physical therapy, acupuncture, dolphin therapy, courses with pathologists, speech therapists, psychologists) in Russia, Alexei's condition remained largely unchanged until his mother learned about Stereotactic Brain Procedure (historically described as MIBR) combined with nerve growth factors implantation at Beijing Puhua International Hospital.
Treatment:
After admission to BPIH in August 2018, Alexei underwent the following treatment protocol:
Stereotactic Brain Procedure (historically described as MIBR) with nerve growth factors implantation:
Traditional Chinese Medicine (TCM):
Rehabilitation Training:
Treatment Results:
New Year Greetings from Alexei's Mother:
"Hi! Everything goes well with Alexei, studying hard at school and also has extra lessons after classes. Very expecting the new year! He can speak more words, interested in more things! He asked for a gift – white bear! This wouldn’t happen before! Thank you very much!!! Please give our as well as Alexei’s wishes to all! We love you very much!!!"
We are thrilled with Alexei's progress and wish him continued improvement and happiness in life.